Sign in
Taking people in United StatesNo phase

Nasal airway device for adults with obstructive sleep apnea who cannot use CPAP

Tests a nasal airway device for obstructive sleep apnea in adults resistant to CPAP.

Key facts

Who runs it
University of Michigan
Where
Ann Arbor, United StatesSee the 2 sites
Trial code
Registry title
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
Status
Recruiting
People taking part
20 people, planned
Started
7 Mar 2025
Expected to end
Dec 2026
Type of study
Interventional
Treatments tested
  • nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device
Record updated
12 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with moderate to severe obstructive sleep apnea who do not use CPAP well or want another option. They will test a nose-to-throat airway device for 1 night in a sleep lab and 30 days at home.

Age
18 Years and older
Sex
All
Disease stage
Moderate to severe obstructive sleep apnea (AHI >= 15), caused by a blocked upper airway.
Earlier treatment
People must not use CPAP enough (at least 4 hours a night on at least 70% of nights), or want another sleep apnea treatment. People who started CPAP within the last 3 months and are actively using it cannot join.

Main reasons for not taking part

  • Being pregnant now
  • Bleeding disorder, need for blood-thinning medicine, or repeated nosebleeds
  • Allergy to silicone, lidocaine or neosynephrine, or severe nasal allergies
  • Airway collapse above the voice box, narrowed lower airway, or tracheobronchomalacia
  • Serious or uncontrolled illness, such as severe breathing or heart disease, or high carbon dioxide levels (>60 mmHg for >10% of sleep time)

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Capacity and willingness to sign consent
  • Patient willingness to commit to and complete study over a 30-day time period
  • Confirmed diagnosis of moderate to severe OSA (AHI >= 15)
  • OSA caused by upper airway obstruction
  • CPAP non-compliant where CPAP compliance is defined as using CPAP for at least 4 hours a night for at least 70% of nights or interest in an alternative sleep apnea therapy
  • Adequate manual dexterity to demonstrate ability to self-insert and remove device

Who cannot take part

  • Need for anticoagulative therapy
  • Active COVID-19 infection
  • Severe nasal allergies
  • Bleeding disorder
  • Restrictive thoracic disorders
  • Silicone, lidocaine, neosynephrine allergy
  • Uncontrolled or serious illness, included but not limited to: severe breathing disorders including hypercapnic respiratory failure, respiratory muscle weakness, bullous lung disease (as seen in some types of emphysema), bypassed upper airway, pneumothorax, pneumomediastinum, etc.; severe heart disease (including heart failure); or pathologically low blood pressure
  • Within 3 months of initiating CPAP use, and actively using CPAP
  • Supraglottic airway collapse
  • Distal airway stenosis
  • Tracheobronchomalacia
  • Currently pregnant
  • More than mild elevation of End-tidal carbon dioxide (ETCO2) or total carbon dioxide (TCO2) values >60 mmHg for >10% of sleep time
  • Recurrent epistaxis

This trial is currently available in United States.

  • Michigan MedicineAnn Arbor, United StatesContact: Zahra Nourmohammadi, PhDTaking people
  • University of MichiganAnn Arbor, United StatesContact: Zahra NourmohammadiTaking people

About the trial

What the trial wants to find out

This pilot study is being done to determine if the nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device can be used in the treatment of OSA in adults. The researchers think that the NPA-OSA device will reduce the number of apneas.

The group in the trial

  • Nasopharyngeal airway deviceTreatment being tested

    A nasopharyngeal airway obstructive sleep apnea ("NPA"-OSA) device will be used for one night in a sleep laboratory and 30 days at home.

    Treatment: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Continuous Positive Airway Pressure (CPAP) Resistant Adult OSA Patients
Plain-language title
Nasal airway device for adults with obstructive sleep apnea who cannot use CPAPGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 March 2026